DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | - | ₹37 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr |
What is the latest Long Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹25 Cr |
How is Long Term Provisions of DIVIS LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹37 Cr | 19.35 | |
| Mar2023 | ₹31 Cr | 16.06 | |
| Mar2022 | ₹27 Cr | 5.07 | |
| Mar2021 | ₹25 Cr | - | |
Compare Long Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹155,503.4 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
| MANKIND PHARMA | ₹82,460.4 Cr | -1.1% | -11.1% | -16.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.6% |
-8.7% |
1.2% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses